nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—AOX1—Methotrexate—colon cancer	0.21	0.395	CbGbCtD
Perphenazine—CYP2B6—Irinotecan—colon cancer	0.0764	0.143	CbGbCtD
Perphenazine—CYP2C9—Capecitabine—colon cancer	0.0653	0.122	CbGbCtD
Perphenazine—CYP2C8—Fluorouracil—colon cancer	0.0555	0.104	CbGbCtD
Perphenazine—CYP1A2—Fluorouracil—colon cancer	0.043	0.0806	CbGbCtD
Perphenazine—CYP2C9—Fluorouracil—colon cancer	0.0387	0.0726	CbGbCtD
Perphenazine—CYP3A4—Irinotecan—colon cancer	0.0235	0.044	CbGbCtD
Perphenazine—CYP3A4—Vincristine—colon cancer	0.0205	0.0384	CbGbCtD
Perphenazine—HTR7—myenteric nerve plexus—colon cancer	0.0156	0.0981	CbGeAlD
Perphenazine—HTR7—vein—colon cancer	0.01	0.0632	CbGeAlD
Perphenazine—HTR2A—myenteric nerve plexus—colon cancer	0.00971	0.0612	CbGeAlD
Perphenazine—HTR2A—vein—colon cancer	0.00626	0.0394	CbGeAlD
Perphenazine—Salivation—Irinotecan—colon cancer	0.00458	0.0277	CcSEcCtD
Perphenazine—AOX1—gall bladder—colon cancer	0.00436	0.0275	CbGeAlD
Perphenazine—Ileus paralytic—Vincristine—colon cancer	0.00422	0.0255	CcSEcCtD
Perphenazine—Slurred speech—Fluorouracil—colon cancer	0.00381	0.023	CcSEcCtD
Perphenazine—Parkinsonism—Fluorouracil—colon cancer	0.00374	0.0226	CcSEcCtD
Perphenazine—Trismus—Capecitabine—colon cancer	0.00356	0.0215	CcSEcCtD
Perphenazine—CALM2—endothelium—colon cancer	0.00355	0.0224	CbGeAlD
Perphenazine—CALM1—endothelium—colon cancer	0.00353	0.0223	CbGeAlD
Perphenazine—Sudden death—Irinotecan—colon cancer	0.00347	0.021	CcSEcCtD
Perphenazine—HTR7—endothelium—colon cancer	0.00345	0.0218	CbGeAlD
Perphenazine—Sudden death—Fluorouracil—colon cancer	0.00332	0.0201	CcSEcCtD
Perphenazine—CALM2—blood vessel—colon cancer	0.00327	0.0206	CbGeAlD
Perphenazine—CALM1—blood vessel—colon cancer	0.00326	0.0205	CbGeAlD
Perphenazine—Akathisia—Irinotecan—colon cancer	0.00321	0.0194	CcSEcCtD
Perphenazine—HTR7—blood vessel—colon cancer	0.00318	0.0201	CbGeAlD
Perphenazine—Inappropriate antidiuretic hormone secretion—Vincristine—colon cancer	0.00314	0.019	CcSEcCtD
Perphenazine—CALM2—gall bladder—colon cancer	0.00308	0.0194	CbGeAlD
Perphenazine—Ileus paralytic—Capecitabine—colon cancer	0.00275	0.0166	CcSEcCtD
Perphenazine—CYP2C18—digestive system—colon cancer	0.00271	0.0171	CbGeAlD
Perphenazine—Retinal disorder—Methotrexate—colon cancer	0.00248	0.015	CcSEcCtD
Perphenazine—CYP2C18—vagina—colon cancer	0.00239	0.0151	CbGeAlD
Perphenazine—Sudden death—Capecitabine—colon cancer	0.00232	0.014	CcSEcCtD
Perphenazine—HTR2A—endothelium—colon cancer	0.00215	0.0136	CbGeAlD
Perphenazine—AOX1—renal system—colon cancer	0.00209	0.0132	CbGeAlD
Perphenazine—CYP2C18—liver—colon cancer	0.00202	0.0127	CbGeAlD
Perphenazine—HTR2A—blood vessel—colon cancer	0.00199	0.0125	CbGeAlD
Perphenazine—CALM3—smooth muscle tissue—colon cancer	0.00196	0.0123	CbGeAlD
Perphenazine—CALM2—embryo—colon cancer	0.00195	0.0123	CbGeAlD
Perphenazine—CALM1—embryo—colon cancer	0.00194	0.0123	CbGeAlD
Perphenazine—Dysarthria—Irinotecan—colon cancer	0.00188	0.0114	CcSEcCtD
Perphenazine—Dysarthria—Fluorouracil—colon cancer	0.0018	0.0109	CcSEcCtD
Perphenazine—Sudden death—Methotrexate—colon cancer	0.00173	0.0105	CcSEcCtD
Perphenazine—Salivary hypersecretion—Irinotecan—colon cancer	0.00173	0.0104	CcSEcCtD
Perphenazine—AOX1—digestive system—colon cancer	0.00171	0.0108	CbGeAlD
Perphenazine—Dermatitis contact—Fluorouracil—colon cancer	0.00168	0.0102	CcSEcCtD
Perphenazine—Throat sore—Capecitabine—colon cancer	0.00165	0.00997	CcSEcCtD
Perphenazine—Urine output increased—Vincristine—colon cancer	0.00165	0.00997	CcSEcCtD
Perphenazine—Oropharyngeal discomfort—Capecitabine—colon cancer	0.00163	0.00989	CcSEcCtD
Perphenazine—Photophobia—Fluorouracil—colon cancer	0.0016	0.00966	CcSEcCtD
Perphenazine—CALM2—epithelium—colon cancer	0.00159	0.01	CbGeAlD
Perphenazine—CALM1—epithelium—colon cancer	0.00159	0.01	CbGeAlD
Perphenazine—HTR7—epithelium—colon cancer	0.00155	0.00977	CbGeAlD
Perphenazine—CALM2—smooth muscle tissue—colon cancer	0.00154	0.00968	CbGeAlD
Perphenazine—CALM1—smooth muscle tissue—colon cancer	0.00153	0.00964	CbGeAlD
Perphenazine—AOX1—vagina—colon cancer	0.00151	0.00954	CbGeAlD
Perphenazine—Polyuria—Vincristine—colon cancer	0.00151	0.00912	CcSEcCtD
Perphenazine—HTR1A—renal system—colon cancer	0.0015	0.00948	CbGeAlD
Perphenazine—HTR7—smooth muscle tissue—colon cancer	0.00149	0.00941	CbGeAlD
Perphenazine—CALM2—renal system—colon cancer	0.00148	0.00932	CbGeAlD
Perphenazine—CALM1—renal system—colon cancer	0.00147	0.00928	CbGeAlD
Perphenazine—HTR7—renal system—colon cancer	0.00144	0.00906	CbGeAlD
Perphenazine—CALM3—bone marrow—colon cancer	0.00142	0.00897	CbGeAlD
Perphenazine—Photosensitivity—Fluorouracil—colon cancer	0.00141	0.00851	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Irinotecan—colon cancer	0.00137	0.00826	CcSEcCtD
Perphenazine—CALM3—vagina—colon cancer	0.00136	0.00859	CbGeAlD
Perphenazine—Anaphylactoid reaction—Irinotecan—colon cancer	0.00133	0.00806	CcSEcCtD
Perphenazine—Oropharyngeal pain—Capecitabine—colon cancer	0.00131	0.00791	CcSEcCtD
Perphenazine—AOX1—liver—colon cancer	0.00128	0.00805	CbGeAlD
Perphenazine—Lethargy—Fluorouracil—colon cancer	0.00126	0.00762	CcSEcCtD
Perphenazine—Urinary retention—Vincristine—colon cancer	0.00126	0.00761	CcSEcCtD
Perphenazine—Cardiac arrest—Vincristine—colon cancer	0.00126	0.00761	CcSEcCtD
Perphenazine—Dysarthria—Capecitabine—colon cancer	0.00126	0.0076	CcSEcCtD
Perphenazine—Ataxia—Vincristine—colon cancer	0.00125	0.00753	CcSEcCtD
Perphenazine—CALM2—lymphoid tissue—colon cancer	0.00123	0.00774	CbGeAlD
Perphenazine—Cardiac arrest—Irinotecan—colon cancer	0.00123	0.00741	CcSEcCtD
Perphenazine—CYP2C8—renal system—colon cancer	0.00123	0.00772	CbGeAlD
Perphenazine—CALM1—lymphoid tissue—colon cancer	0.00122	0.0077	CbGeAlD
Perphenazine—CALM2—digestive system—colon cancer	0.00121	0.00764	CbGeAlD
Perphenazine—CALM1—digestive system—colon cancer	0.00121	0.00761	CbGeAlD
Perphenazine—HTR2A—embryo—colon cancer	0.00118	0.00747	CbGeAlD
Perphenazine—HTR7—digestive system—colon cancer	0.00118	0.00743	CbGeAlD
Perphenazine—Orthostatic hypotension—Irinotecan—colon cancer	0.00118	0.00712	CcSEcCtD
Perphenazine—Cardiac arrest—Fluorouracil—colon cancer	0.00117	0.0071	CcSEcCtD
Perphenazine—Muscular weakness—Vincristine—colon cancer	0.00117	0.00706	CcSEcCtD
Perphenazine—Ataxia—Fluorouracil—colon cancer	0.00116	0.00702	CcSEcCtD
Perphenazine—HRH1—epithelium—colon cancer	0.00116	0.00729	CbGeAlD
Perphenazine—CYP2C19—digestive system—colon cancer	0.00115	0.00726	CbGeAlD
Perphenazine—CALM3—liver—colon cancer	0.00115	0.00725	CbGeAlD
Perphenazine—CYP1A2—renal system—colon cancer	0.00115	0.00723	CbGeAlD
Perphenazine—CALM2—bone marrow—colon cancer	0.00112	0.00705	CbGeAlD
Perphenazine—HRH1—smooth muscle tissue—colon cancer	0.00112	0.00703	CbGeAlD
Perphenazine—CALM1—bone marrow—colon cancer	0.00111	0.00701	CbGeAlD
Perphenazine—CYP2B6—renal system—colon cancer	0.0011	0.00693	CbGeAlD
Perphenazine—Muscular weakness—Fluorouracil—colon cancer	0.00109	0.00659	CcSEcCtD
Perphenazine—Pancytopenia—Vincristine—colon cancer	0.00109	0.00657	CcSEcCtD
Perphenazine—Urine output increased—Capecitabine—colon cancer	0.00108	0.0065	CcSEcCtD
Perphenazine—CALM2—vagina—colon cancer	0.00107	0.00675	CbGeAlD
Perphenazine—Dysphagia—Fluorouracil—colon cancer	0.00107	0.00645	CcSEcCtD
Perphenazine—CALM1—vagina—colon cancer	0.00107	0.00672	CbGeAlD
Perphenazine—Eosinophilia—Fluorouracil—colon cancer	0.00106	0.00639	CcSEcCtD
Perphenazine—Photosensitivity reaction—Vincristine—colon cancer	0.00104	0.00632	CcSEcCtD
Perphenazine—CYP2C19—vagina—colon cancer	0.00102	0.00641	CbGeAlD
Perphenazine—Pancytopenia—Fluorouracil—colon cancer	0.00101	0.00613	CcSEcCtD
Perphenazine—Photosensitivity—Capecitabine—colon cancer	0.000983	0.00594	CcSEcCtD
Perphenazine—Polyuria—Capecitabine—colon cancer	0.000983	0.00594	CcSEcCtD
Perphenazine—AOX1—lymph node—colon cancer	0.000979	0.00617	CbGeAlD
Perphenazine—Photosensitivity reaction—Fluorouracil—colon cancer	0.000974	0.00589	CcSEcCtD
Perphenazine—Jaundice—Irinotecan—colon cancer	0.000969	0.00586	CcSEcCtD
Perphenazine—HTR2A—epithelium—colon cancer	0.000967	0.00609	CbGeAlD
Perphenazine—Haemolytic anaemia—Capecitabine—colon cancer	0.000956	0.00578	CcSEcCtD
Perphenazine—CYP1A2—digestive system—colon cancer	0.000941	0.00593	CbGeAlD
Perphenazine—Dysarthria—Methotrexate—colon cancer	0.000936	0.00566	CcSEcCtD
Perphenazine—HTR2A—smooth muscle tissue—colon cancer	0.000931	0.00587	CbGeAlD
Perphenazine—Dermatitis exfoliative—Capecitabine—colon cancer	0.000915	0.00553	CcSEcCtD
Perphenazine—CYP2B6—lymphoid tissue—colon cancer	0.000913	0.00575	CbGeAlD
Perphenazine—Hypoaesthesia—Vincristine—colon cancer	0.000911	0.00551	CcSEcCtD
Perphenazine—Bradycardia—Irinotecan—colon cancer	0.000908	0.00549	CcSEcCtD
Perphenazine—CALM2—liver—colon cancer	0.000903	0.00569	CbGeAlD
Perphenazine—CYP2B6—digestive system—colon cancer	0.000902	0.00568	CbGeAlD
Perphenazine—CALM1—liver—colon cancer	0.000899	0.00567	CbGeAlD
Perphenazine—HTR2A—renal system—colon cancer	0.000897	0.00565	CbGeAlD
Perphenazine—CYP2C9—digestive system—colon cancer	0.000893	0.00563	CbGeAlD
Perphenazine—Agranulocytosis—Fluorouracil—colon cancer	0.000888	0.00537	CcSEcCtD
Perphenazine—CYP2C8—vagina—colon cancer	0.000888	0.00559	CbGeAlD
Perphenazine—CALM3—lymph node—colon cancer	0.000882	0.00556	CbGeAlD
Perphenazine—Lethargy—Capecitabine—colon cancer	0.000881	0.00533	CcSEcCtD
Perphenazine—HRH1—digestive system—colon cancer	0.00088	0.00555	CbGeAlD
Perphenazine—HTR7—liver—colon cancer	0.000879	0.00554	CbGeAlD
Perphenazine—CYP2C19—liver—colon cancer	0.000858	0.00541	CbGeAlD
Perphenazine—Hypoaesthesia—Fluorouracil—colon cancer	0.00085	0.00514	CcSEcCtD
Perphenazine—CYP3A4—renal system—colon cancer	0.00083	0.00523	CbGeAlD
Perphenazine—Urinary retention—Capecitabine—colon cancer	0.000821	0.00496	CcSEcCtD
Perphenazine—Cardiac arrest—Capecitabine—colon cancer	0.000821	0.00496	CcSEcCtD
Perphenazine—CYP2D6—renal system—colon cancer	0.000817	0.00515	CbGeAlD
Perphenazine—Ataxia—Capecitabine—colon cancer	0.000812	0.00491	CcSEcCtD
Perphenazine—Urine output increased—Methotrexate—colon cancer	0.0008	0.00484	CcSEcCtD
Perphenazine—CYP2B6—vagina—colon cancer	0.000796	0.00502	CbGeAlD
Perphenazine—Gynaecomastia—Methotrexate—colon cancer	0.000792	0.00479	CcSEcCtD
Perphenazine—Orthostatic hypotension—Capecitabine—colon cancer	0.000788	0.00477	CcSEcCtD
Perphenazine—HRH1—vagina—colon cancer	0.000778	0.0049	CbGeAlD
Perphenazine—ADRA2A—vagina—colon cancer	0.000764	0.00481	CbGeAlD
Perphenazine—Muscular weakness—Capecitabine—colon cancer	0.000761	0.0046	CcSEcCtD
Perphenazine—CYP2C8—liver—colon cancer	0.000749	0.00472	CbGeAlD
Perphenazine—Muscle spasms—Irinotecan—colon cancer	0.000747	0.00451	CcSEcCtD
Perphenazine—Dysphagia—Capecitabine—colon cancer	0.000746	0.00451	CcSEcCtD
Perphenazine—Asthma—Capecitabine—colon cancer	0.000746	0.00451	CcSEcCtD
Perphenazine—Erythema—Fluorouracil—colon cancer	0.000744	0.0045	CcSEcCtD
Perphenazine—HTR2A—digestive system—colon cancer	0.000735	0.00463	CbGeAlD
Perphenazine—Agitation—Vincristine—colon cancer	0.000733	0.00443	CcSEcCtD
Perphenazine—Photosensitivity—Methotrexate—colon cancer	0.000732	0.00442	CcSEcCtD
Perphenazine—Polyuria—Methotrexate—colon cancer	0.000732	0.00442	CcSEcCtD
Perphenazine—Leukopenia—Vincristine—colon cancer	0.000714	0.00432	CcSEcCtD
Perphenazine—Pancytopenia—Capecitabine—colon cancer	0.000708	0.00428	CcSEcCtD
Perphenazine—Vision blurred—Fluorouracil—colon cancer	0.000701	0.00424	CcSEcCtD
Perphenazine—CYP1A2—liver—colon cancer	0.000701	0.00442	CbGeAlD
Perphenazine—Syncope—Irinotecan—colon cancer	0.000696	0.00421	CcSEcCtD
Perphenazine—Leukopenia—Irinotecan—colon cancer	0.000695	0.0042	CcSEcCtD
Perphenazine—CALM2—lymph node—colon cancer	0.000693	0.00437	CbGeAlD
Perphenazine—Convulsion—Vincristine—colon cancer	0.000691	0.00418	CcSEcCtD
Perphenazine—CALM1—lymph node—colon cancer	0.00069	0.00435	CbGeAlD
Perphenazine—Hypertension—Vincristine—colon cancer	0.000688	0.00416	CcSEcCtD
Perphenazine—Loss of consciousness—Irinotecan—colon cancer	0.000683	0.00413	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Methotrexate—colon cancer	0.000681	0.00412	CcSEcCtD
Perphenazine—Photosensitivity reaction—Capecitabine—colon cancer	0.000681	0.00412	CcSEcCtD
Perphenazine—CYP3A4—digestive system—colon cancer	0.000681	0.00429	CbGeAlD
Perphenazine—Cough—Irinotecan—colon cancer	0.000678	0.0041	CcSEcCtD
Perphenazine—Hyperglycaemia—Capecitabine—colon cancer	0.000673	0.00407	CcSEcCtD
Perphenazine—CYP2B6—liver—colon cancer	0.000672	0.00423	CbGeAlD
Perphenazine—Hypertension—Irinotecan—colon cancer	0.00067	0.00405	CcSEcCtD
Perphenazine—CYP2D6—digestive system—colon cancer	0.00067	0.00422	CbGeAlD
Perphenazine—Leukopenia—Fluorouracil—colon cancer	0.000666	0.00403	CcSEcCtD
Perphenazine—CYP2C9—liver—colon cancer	0.000665	0.00419	CbGeAlD
Perphenazine—Flupentixol—ABCB1—colon cancer	0.000665	0.16	CrCbGaD
Perphenazine—Anaphylactoid reaction—Methotrexate—colon cancer	0.000664	0.00401	CcSEcCtD
Perphenazine—Lethargy—Methotrexate—colon cancer	0.000656	0.00396	CcSEcCtD
Perphenazine—Anaphylactic shock—Vincristine—colon cancer	0.000651	0.00394	CcSEcCtD
Perphenazine—HTR2A—vagina—colon cancer	0.000649	0.00409	CbGeAlD
Perphenazine—Jaundice—Capecitabine—colon cancer	0.000648	0.00392	CcSEcCtD
Perphenazine—Infection—Vincristine—colon cancer	0.000647	0.00391	CcSEcCtD
Perphenazine—Convulsion—Fluorouracil—colon cancer	0.000644	0.0039	CcSEcCtD
Perphenazine—Confusional state—Irinotecan—colon cancer	0.000639	0.00386	CcSEcCtD
Perphenazine—Anaphylactic shock—Irinotecan—colon cancer	0.000634	0.00383	CcSEcCtD
Perphenazine—Infection—Irinotecan—colon cancer	0.00063	0.00381	CcSEcCtD
Perphenazine—Shock—Irinotecan—colon cancer	0.000624	0.00377	CcSEcCtD
Perphenazine—Agranulocytosis—Capecitabine—colon cancer	0.000621	0.00375	CcSEcCtD
Perphenazine—Anorexia—Vincristine—colon cancer	0.00062	0.00375	CcSEcCtD
Perphenazine—Confusional state—Fluorouracil—colon cancer	0.000612	0.0037	CcSEcCtD
Perphenazine—Hypotension—Vincristine—colon cancer	0.000608	0.00368	CcSEcCtD
Perphenazine—Bradycardia—Capecitabine—colon cancer	0.000608	0.00368	CcSEcCtD
Perphenazine—Anaphylactic shock—Fluorouracil—colon cancer	0.000607	0.00367	CcSEcCtD
Perphenazine—Anorexia—Irinotecan—colon cancer	0.000604	0.00365	CcSEcCtD
Perphenazine—Ataxia—Methotrexate—colon cancer	0.000604	0.00365	CcSEcCtD
Perphenazine—Infection—Fluorouracil—colon cancer	0.000603	0.00365	CcSEcCtD
Perphenazine—Hypoaesthesia—Capecitabine—colon cancer	0.000594	0.00359	CcSEcCtD
Perphenazine—Tachycardia—Fluorouracil—colon cancer	0.000592	0.00358	CcSEcCtD
Perphenazine—Hypotension—Irinotecan—colon cancer	0.000592	0.00358	CcSEcCtD
Perphenazine—Insomnia—Vincristine—colon cancer	0.000589	0.00356	CcSEcCtD
Perphenazine—Oedema peripheral—Capecitabine—colon cancer	0.000588	0.00356	CcSEcCtD
Perphenazine—Anorexia—Fluorouracil—colon cancer	0.000579	0.0035	CcSEcCtD
Perphenazine—Insomnia—Irinotecan—colon cancer	0.000573	0.00347	CcSEcCtD
Perphenazine—Hypotension—Fluorouracil—colon cancer	0.000567	0.00343	CcSEcCtD
Perphenazine—Decreased appetite—Vincristine—colon cancer	0.000566	0.00342	CcSEcCtD
Perphenazine—Dyspnoea—Irinotecan—colon cancer	0.000565	0.00342	CcSEcCtD
Perphenazine—Somnolence—Irinotecan—colon cancer	0.000563	0.00341	CcSEcCtD
Perphenazine—Pain—Vincristine—colon cancer	0.000557	0.00337	CcSEcCtD
Perphenazine—Constipation—Vincristine—colon cancer	0.000557	0.00337	CcSEcCtD
Perphenazine—Asthma—Methotrexate—colon cancer	0.000555	0.00336	CcSEcCtD
Perphenazine—Decreased appetite—Irinotecan—colon cancer	0.000551	0.00333	CcSEcCtD
Perphenazine—Eosinophilia—Methotrexate—colon cancer	0.00055	0.00332	CcSEcCtD
Perphenazine—Insomnia—Fluorouracil—colon cancer	0.000549	0.00332	CcSEcCtD
Perphenazine—HTR2A—liver—colon cancer	0.000548	0.00345	CbGeAlD
Perphenazine—Constipation—Irinotecan—colon cancer	0.000542	0.00328	CcSEcCtD
Perphenazine—Pain—Irinotecan—colon cancer	0.000542	0.00328	CcSEcCtD
Perphenazine—Dyspnoea—Fluorouracil—colon cancer	0.000541	0.00327	CcSEcCtD
Perphenazine—Somnolence—Fluorouracil—colon cancer	0.00054	0.00326	CcSEcCtD
Perphenazine—Decreased appetite—Fluorouracil—colon cancer	0.000528	0.00319	CcSEcCtD
Perphenazine—Pancytopenia—Methotrexate—colon cancer	0.000527	0.00319	CcSEcCtD
Perphenazine—Erythema—Capecitabine—colon cancer	0.00052	0.00314	CcSEcCtD
Perphenazine—Pain—Fluorouracil—colon cancer	0.000519	0.00314	CcSEcCtD
Perphenazine—Body temperature increased—Vincristine—colon cancer	0.000514	0.00311	CcSEcCtD
Perphenazine—CYP3A4—liver—colon cancer	0.000507	0.0032	CbGeAlD
Perphenazine—Photosensitivity reaction—Methotrexate—colon cancer	0.000507	0.00306	CcSEcCtD
Perphenazine—HRH1—lymph node—colon cancer	0.000503	0.00317	CbGeAlD
Perphenazine—Body temperature increased—Irinotecan—colon cancer	0.000501	0.00303	CcSEcCtD
Perphenazine—Muscle spasms—Capecitabine—colon cancer	0.0005	0.00302	CcSEcCtD
Perphenazine—CYP2D6—liver—colon cancer	0.000499	0.00315	CbGeAlD
Perphenazine—Drowsiness—Methotrexate—colon cancer	0.000495	0.00299	CcSEcCtD
Perphenazine—ADRA2A—lymph node—colon cancer	0.000494	0.00311	CbGeAlD
Perphenazine—Vision blurred—Capecitabine—colon cancer	0.00049	0.00296	CcSEcCtD
Perphenazine—Urticaria—Fluorouracil—colon cancer	0.000482	0.00292	CcSEcCtD
Perphenazine—Body temperature increased—Fluorouracil—colon cancer	0.00048	0.0029	CcSEcCtD
Perphenazine—Hypersensitivity—Vincristine—colon cancer	0.000479	0.0029	CcSEcCtD
Perphenazine—Hypersensitivity—Irinotecan—colon cancer	0.000467	0.00282	CcSEcCtD
Perphenazine—Syncope—Capecitabine—colon cancer	0.000466	0.00282	CcSEcCtD
Perphenazine—Leukopenia—Capecitabine—colon cancer	0.000465	0.00281	CcSEcCtD
Perphenazine—Agranulocytosis—Methotrexate—colon cancer	0.000462	0.00279	CcSEcCtD
Perphenazine—Loss of consciousness—Capecitabine—colon cancer	0.000457	0.00276	CcSEcCtD
Perphenazine—Cough—Capecitabine—colon cancer	0.000454	0.00274	CcSEcCtD
Perphenazine—Hypertension—Capecitabine—colon cancer	0.000449	0.00271	CcSEcCtD
Perphenazine—Domperidone—ABCB1—colon cancer	0.000447	0.108	CrCbGaD
Perphenazine—Hypersensitivity—Fluorouracil—colon cancer	0.000447	0.0027	CcSEcCtD
Perphenazine—Diarrhoea—Vincristine—colon cancer	0.000445	0.00269	CcSEcCtD
Perphenazine—Diarrhoea—Irinotecan—colon cancer	0.000434	0.00262	CcSEcCtD
Perphenazine—Dry mouth—Capecitabine—colon cancer	0.000433	0.00262	CcSEcCtD
Perphenazine—Dizziness—Vincristine—colon cancer	0.00043	0.0026	CcSEcCtD
Perphenazine—Pruritus—Fluorouracil—colon cancer	0.000429	0.0026	CcSEcCtD
Perphenazine—Confusional state—Capecitabine—colon cancer	0.000428	0.00259	CcSEcCtD
Perphenazine—Infection—Capecitabine—colon cancer	0.000421	0.00255	CcSEcCtD
Perphenazine—Dizziness—Irinotecan—colon cancer	0.000419	0.00253	CcSEcCtD
Perphenazine—Shock—Capecitabine—colon cancer	0.000417	0.00252	CcSEcCtD
Perphenazine—Diarrhoea—Fluorouracil—colon cancer	0.000415	0.00251	CcSEcCtD
Perphenazine—Tachycardia—Capecitabine—colon cancer	0.000414	0.0025	CcSEcCtD
Perphenazine—Headache—Vincristine—colon cancer	0.000408	0.00247	CcSEcCtD
Perphenazine—Anorexia—Capecitabine—colon cancer	0.000404	0.00245	CcSEcCtD
Perphenazine—Dizziness—Fluorouracil—colon cancer	0.000401	0.00243	CcSEcCtD
Perphenazine—Headache—Irinotecan—colon cancer	0.000397	0.0024	CcSEcCtD
Perphenazine—Hypotension—Capecitabine—colon cancer	0.000396	0.0024	CcSEcCtD
Perphenazine—Erythema—Methotrexate—colon cancer	0.000387	0.00234	CcSEcCtD
Perphenazine—Insomnia—Capecitabine—colon cancer	0.000384	0.00232	CcSEcCtD
Perphenazine—Headache—Fluorouracil—colon cancer	0.00038	0.0023	CcSEcCtD
Perphenazine—Dyspnoea—Capecitabine—colon cancer	0.000378	0.00229	CcSEcCtD
Perphenazine—Nefazodone—ABCB1—colon cancer	0.000371	0.0893	CrCbGaD
Perphenazine—Decreased appetite—Capecitabine—colon cancer	0.000369	0.00223	CcSEcCtD
Perphenazine—Vision blurred—Methotrexate—colon cancer	0.000365	0.0022	CcSEcCtD
Perphenazine—Constipation—Capecitabine—colon cancer	0.000363	0.00219	CcSEcCtD
Perphenazine—Pain—Capecitabine—colon cancer	0.000363	0.00219	CcSEcCtD
Perphenazine—Triflupromazine—ABCB1—colon cancer	0.000362	0.087	CrCbGaD
Perphenazine—Leukopenia—Methotrexate—colon cancer	0.000346	0.00209	CcSEcCtD
Perphenazine—Aripiprazole—ABCB1—colon cancer	0.000345	0.083	CrCbGaD
Perphenazine—Trazodone—ABCB1—colon cancer	0.000344	0.0826	CrCbGaD
Perphenazine—Cough—Methotrexate—colon cancer	0.000338	0.00204	CcSEcCtD
Perphenazine—Urticaria—Capecitabine—colon cancer	0.000337	0.00204	CcSEcCtD
Perphenazine—Body temperature increased—Capecitabine—colon cancer	0.000335	0.00203	CcSEcCtD
Perphenazine—Convulsion—Methotrexate—colon cancer	0.000335	0.00203	CcSEcCtD
Perphenazine—Confusional state—Methotrexate—colon cancer	0.000318	0.00193	CcSEcCtD
Perphenazine—Anaphylactic shock—Methotrexate—colon cancer	0.000316	0.00191	CcSEcCtD
Perphenazine—Infection—Methotrexate—colon cancer	0.000314	0.0019	CcSEcCtD
Perphenazine—Hypersensitivity—Capecitabine—colon cancer	0.000313	0.00189	CcSEcCtD
Perphenazine—Anorexia—Methotrexate—colon cancer	0.000301	0.00182	CcSEcCtD
Perphenazine—Pruritus—Capecitabine—colon cancer	0.0003	0.00181	CcSEcCtD
Perphenazine—Hypotension—Methotrexate—colon cancer	0.000295	0.00178	CcSEcCtD
Perphenazine—Diarrhoea—Capecitabine—colon cancer	0.00029	0.00176	CcSEcCtD
Perphenazine—Insomnia—Methotrexate—colon cancer	0.000286	0.00173	CcSEcCtD
Perphenazine—Dyspnoea—Methotrexate—colon cancer	0.000282	0.0017	CcSEcCtD
Perphenazine—Somnolence—Methotrexate—colon cancer	0.000281	0.0017	CcSEcCtD
Perphenazine—Dizziness—Capecitabine—colon cancer	0.000281	0.0017	CcSEcCtD
Perphenazine—Fluphenazine—ABCB1—colon cancer	0.000278	0.0669	CrCbGaD
Perphenazine—Decreased appetite—Methotrexate—colon cancer	0.000275	0.00166	CcSEcCtD
Perphenazine—Pain—Methotrexate—colon cancer	0.00027	0.00163	CcSEcCtD
Perphenazine—Headache—Capecitabine—colon cancer	0.000266	0.00161	CcSEcCtD
Perphenazine—Clomipramine—ABCB1—colon cancer	0.000255	0.0612	CrCbGaD
Perphenazine—Chlorprothixene—ABCB1—colon cancer	0.000253	0.0609	CrCbGaD
Perphenazine—Urticaria—Methotrexate—colon cancer	0.000251	0.00152	CcSEcCtD
Perphenazine—Body temperature increased—Methotrexate—colon cancer	0.00025	0.00151	CcSEcCtD
Perphenazine—Hypersensitivity—Methotrexate—colon cancer	0.000233	0.00141	CcSEcCtD
Perphenazine—Promethazine—ABCB1—colon cancer	0.000226	0.0542	CrCbGaD
Perphenazine—Pruritus—Methotrexate—colon cancer	0.000223	0.00135	CcSEcCtD
Perphenazine—Trifluoperazine—ABCB1—colon cancer	0.000223	0.0535	CrCbGaD
Perphenazine—Diarrhoea—Methotrexate—colon cancer	0.000216	0.00131	CcSEcCtD
Perphenazine—Quetiapine—ABCB1—colon cancer	0.000216	0.0519	CrCbGaD
Perphenazine—Dizziness—Methotrexate—colon cancer	0.000209	0.00126	CcSEcCtD
Perphenazine—Headache—Methotrexate—colon cancer	0.000198	0.0012	CcSEcCtD
Perphenazine—Chlorpromazine—ABCB1—colon cancer	0.000175	0.042	CrCbGaD
Perphenazine—HTR2A—GPCR downstream signaling—AKT1—colon cancer	1.23e-05	8.89e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—SRC—colon cancer	1.23e-05	8.88e-05	CbGpPWpGaD
Perphenazine—HRH1—GPCR downstream signaling—AKT1—colon cancer	1.23e-05	8.87e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—SRC—colon cancer	1.22e-05	8.84e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—TP53—colon cancer	1.22e-05	8.83e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—TP53—colon cancer	1.22e-05	8.82e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CASP3—colon cancer	1.22e-05	8.81e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—SRC—colon cancer	1.22e-05	8.8e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—SRC—colon cancer	1.22e-05	8.8e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CASP3—colon cancer	1.22e-05	8.79e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—NRAS—colon cancer	1.21e-05	8.75e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CCND1—colon cancer	1.21e-05	8.71e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—VEGFA—colon cancer	1.2e-05	8.65e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—KRAS—colon cancer	1.2e-05	8.64e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—KRAS—colon cancer	1.2e-05	8.64e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—EGFR—colon cancer	1.2e-05	8.63e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CTNNB1—colon cancer	1.19e-05	8.63e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—VEGFA—colon cancer	1.19e-05	8.61e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—EP300—colon cancer	1.19e-05	8.58e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CCND1—colon cancer	1.19e-05	8.57e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CCND1—colon cancer	1.18e-05	8.55e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—KRAS—colon cancer	1.18e-05	8.55e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PPARG—colon cancer	1.18e-05	8.55e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—NRAS—colon cancer	1.18e-05	8.54e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—NRAS—colon cancer	1.18e-05	8.5e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CTNNB1—colon cancer	1.18e-05	8.49e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PPARG—colon cancer	1.17e-05	8.48e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CTNNB1—colon cancer	1.17e-05	8.47e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—NRAS—colon cancer	1.17e-05	8.46e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—NRAS—colon cancer	1.17e-05	8.46e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—HRAS—colon cancer	1.17e-05	8.44e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—HRAS—colon cancer	1.17e-05	8.44e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CDKN1A—colon cancer	1.17e-05	8.43e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—EGFR—colon cancer	1.16e-05	8.35e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—EGFR—colon cancer	1.16e-05	8.35e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—HRAS—colon cancer	1.15e-05	8.32e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CDKN1A—colon cancer	1.15e-05	8.29e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CDKN1A—colon cancer	1.15e-05	8.27e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—AKT1—colon cancer	1.14e-05	8.2e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—PIK3CA—colon cancer	1.14e-05	8.2e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PTGS2—colon cancer	1.13e-05	8.19e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—KRAS—colon cancer	1.13e-05	8.16e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—MYC—colon cancer	1.13e-05	8.15e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—TGFB1—colon cancer	1.13e-05	8.13e-05	CbGpPWpGaD
Perphenazine—ADRA2A—GPCR downstream signaling—AKT1—colon cancer	1.12e-05	8.09e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—AKT1—colon cancer	1.12e-05	8.07e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—AKT1—colon cancer	1.11e-05	8.05e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—EP300—colon cancer	1.11e-05	8.05e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—ABCB1—colon cancer	1.11e-05	8.04e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—EP300—colon cancer	1.11e-05	8.02e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CASP3—colon cancer	1.11e-05	8.01e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—EGFR—colon cancer	1.1e-05	7.97e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—MYC—colon cancer	1.1e-05	7.96e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TGFB1—colon cancer	1.1e-05	7.94e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—PIK3CA—colon cancer	1.1e-05	7.93e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—PIK3CA—colon cancer	1.1e-05	7.93e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—MYC—colon cancer	1.1e-05	7.92e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TGFB1—colon cancer	1.09e-05	7.9e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—TYMS—colon cancer	1.09e-05	7.89e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—KRAS—colon cancer	1.09e-05	7.89e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—KRAS—colon cancer	1.09e-05	7.89e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—EP300—colon cancer	1.09e-05	7.89e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—MYC—colon cancer	1.09e-05	7.88e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—MYC—colon cancer	1.09e-05	7.88e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—EP300—colon cancer	1.09e-05	7.87e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.09e-05	7.87e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—TGFB1—colon cancer	1.09e-05	7.87e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—TGFB1—colon cancer	1.09e-05	7.87e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—PIK3CA—colon cancer	1.09e-05	7.86e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—EP300—colon cancer	1.08e-05	7.83e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CCND1—colon cancer	1.08e-05	7.8e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—SRC—colon cancer	1.08e-05	7.8e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—EGFR—colon cancer	1.08e-05	7.78e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—EGFR—colon cancer	1.07e-05	7.74e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CTNNB1—colon cancer	1.07e-05	7.72e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—EGFR—colon cancer	1.07e-05	7.71e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—EGFR—colon cancer	1.07e-05	7.71e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—SRC—colon cancer	1.06e-05	7.67e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—SRC—colon cancer	1.06e-05	7.66e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—TP53—colon cancer	1.05e-05	7.6e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—VEGFA—colon cancer	1.05e-05	7.59e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—HRAS—colon cancer	1.05e-05	7.59e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—EP300—colon cancer	1.05e-05	7.58e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—EP300—colon cancer	1.05e-05	7.58e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CDKN1A—colon cancer	1.04e-05	7.54e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—KRAS—colon cancer	1.04e-05	7.53e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—NRAS—colon cancer	1.04e-05	7.5e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—PIK3CA—colon cancer	1.04e-05	7.49e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—VEGFA—colon cancer	1.03e-05	7.47e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—VEGFA—colon cancer	1.03e-05	7.46e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—AKT1—colon cancer	1.03e-05	7.46e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—AKT1—colon cancer	1.03e-05	7.45e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—NRAS—colon cancer	1.02e-05	7.38e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—NRAS—colon cancer	1.02e-05	7.37e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—KRAS—colon cancer	1.02e-05	7.35e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—AKT1—colon cancer	1.02e-05	7.34e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—HRAS—colon cancer	1.02e-05	7.34e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—HRAS—colon cancer	1.02e-05	7.34e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—KRAS—colon cancer	1.01e-05	7.32e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PTGS2—colon cancer	1.01e-05	7.31e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CASP3—colon cancer	1.01e-05	7.31e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—KRAS—colon cancer	1.01e-05	7.29e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—KRAS—colon cancer	1.01e-05	7.29e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—HRAS—colon cancer	1.01e-05	7.27e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—PIK3CA—colon cancer	1e-05	7.25e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—PIK3CA—colon cancer	1e-05	7.25e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PPARG—colon cancer	1e-05	7.24e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—EP300—colon cancer	9.94e-06	7.18e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CCND1—colon cancer	9.85e-06	7.12e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CASP3—colon cancer	9.79e-06	7.07e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CASP3—colon cancer	9.79e-06	7.07e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CTNNB1—colon cancer	9.75e-06	7.05e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MYC—colon cancer	9.67e-06	6.99e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—SRC—colon cancer	9.66e-06	6.98e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TGFB1—colon cancer	9.65e-06	6.97e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—HRAS—colon cancer	9.6e-06	6.93e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—PIK3CA—colon cancer	9.58e-06	6.92e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CDKN1A—colon cancer	9.53e-06	6.88e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CCND1—colon cancer	9.53e-06	6.88e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CCND1—colon cancer	9.53e-06	6.88e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MYC—colon cancer	9.52e-06	6.88e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MYC—colon cancer	9.5e-06	6.86e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TGFB1—colon cancer	9.49e-06	6.86e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TGFB1—colon cancer	9.47e-06	6.84e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—EGFR—colon cancer	9.46e-06	6.83e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CTNNB1—colon cancer	9.44e-06	6.82e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CTNNB1—colon cancer	9.44e-06	6.82e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—EP300—colon cancer	9.43e-06	6.81e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—VEGFA—colon cancer	9.41e-06	6.8e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—PIK3CA—colon cancer	9.35e-06	6.76e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PTGS2—colon cancer	9.31e-06	6.73e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—EGFR—colon cancer	9.31e-06	6.73e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—PIK3CA—colon cancer	9.3e-06	6.72e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—NRAS—colon cancer	9.3e-06	6.72e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—EGFR—colon cancer	9.29e-06	6.71e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—HRAS—colon cancer	9.28e-06	6.71e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—HRAS—colon cancer	9.28e-06	6.71e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—AKT1—colon cancer	9.27e-06	6.7e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—PIK3CA—colon cancer	9.26e-06	6.69e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—PIK3CA—colon cancer	9.26e-06	6.69e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PTGS2—colon cancer	9.23e-06	6.67e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CDKN1A—colon cancer	9.22e-06	6.66e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CDKN1A—colon cancer	9.22e-06	6.66e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—EP300—colon cancer	9.07e-06	6.55e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TP53—colon cancer	9.05e-06	6.54e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TP53—colon cancer	9e-06	6.5e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—AKT1—colon cancer	8.97e-06	6.48e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—AKT1—colon cancer	8.97e-06	6.48e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—KRAS—colon cancer	8.94e-06	6.46e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—AKT1—colon cancer	8.88e-06	6.42e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—HRAS—colon cancer	8.86e-06	6.4e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—SRC—colon cancer	8.82e-06	6.37e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—KRAS—colon cancer	8.79e-06	6.35e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—PIK3CA—colon cancer	8.79e-06	6.35e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—KRAS—colon cancer	8.78e-06	6.34e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—EP300—colon cancer	8.77e-06	6.34e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—EP300—colon cancer	8.77e-06	6.34e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MYC—colon cancer	8.66e-06	6.26e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—HRAS—colon cancer	8.65e-06	6.25e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TGFB1—colon cancer	8.64e-06	6.24e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—HRAS—colon cancer	8.61e-06	6.22e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—VEGFA—colon cancer	8.59e-06	6.2e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—HRAS—colon cancer	8.57e-06	6.19e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—HRAS—colon cancer	8.57e-06	6.19e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—SRC—colon cancer	8.53e-06	6.16e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—SRC—colon cancer	8.53e-06	6.16e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—NRAS—colon cancer	8.48e-06	6.13e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—AKT1—colon cancer	8.47e-06	6.12e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—EGFR—colon cancer	8.47e-06	6.12e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—EP300—colon cancer	8.42e-06	6.08e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—VEGFA—colon cancer	8.31e-06	6e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—VEGFA—colon cancer	8.31e-06	6e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—PIK3CA—colon cancer	8.24e-06	5.95e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—PIK3CA—colon cancer	8.21e-06	5.93e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—NRAS—colon cancer	8.2e-06	5.93e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—NRAS—colon cancer	8.2e-06	5.93e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—AKT1—colon cancer	8.2e-06	5.92e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—AKT1—colon cancer	8.2e-06	5.92e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—PIK3CA—colon cancer	8.08e-06	5.84e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—PIK3CA—colon cancer	8.06e-06	5.82e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—PIK3CA—colon cancer	8.02e-06	5.79e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—KRAS—colon cancer	8e-06	5.78e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TP53—colon cancer	7.94e-06	5.74e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MYC—colon cancer	7.9e-06	5.71e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PTGS2—colon cancer	7.89e-06	5.7e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TGFB1—colon cancer	7.88e-06	5.69e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—AKT1—colon cancer	7.82e-06	5.65e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TP53—colon cancer	7.82e-06	5.65e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TP53—colon cancer	7.8e-06	5.63e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—PIK3CA—colon cancer	7.76e-06	5.61e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—PIK3CA—colon cancer	7.76e-06	5.61e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—EP300—colon cancer	7.74e-06	5.59e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PPARG—colon cancer	7.74e-06	5.59e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—EGFR—colon cancer	7.73e-06	5.58e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—EP300—colon cancer	7.68e-06	5.55e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MYC—colon cancer	7.64e-06	5.52e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MYC—colon cancer	7.64e-06	5.52e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—AKT1—colon cancer	7.64e-06	5.52e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TGFB1—colon cancer	7.62e-06	5.51e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TGFB1—colon cancer	7.62e-06	5.51e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—AKT1—colon cancer	7.6e-06	5.49e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—HRAS—colon cancer	7.6e-06	5.49e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—AKT1—colon cancer	7.57e-06	5.47e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—AKT1—colon cancer	7.57e-06	5.47e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—EGFR—colon cancer	7.48e-06	5.4e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—EGFR—colon cancer	7.48e-06	5.4e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—HRAS—colon cancer	7.47e-06	5.4e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—HRAS—colon cancer	7.46e-06	5.39e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—PIK3CA—colon cancer	7.35e-06	5.31e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—KRAS—colon cancer	7.3e-06	5.27e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—AKT1—colon cancer	7.18e-06	5.19e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TP53—colon cancer	7.11e-06	5.14e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—KRAS—colon cancer	7.06e-06	5.1e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—KRAS—colon cancer	7.06e-06	5.1e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PIK3CA—colon cancer	6.98e-06	5.04e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—HRAS—colon cancer	6.8e-06	4.91e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—AKT1—colon cancer	6.73e-06	4.86e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—AKT1—colon cancer	6.71e-06	4.85e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—PIK3CA—colon cancer	6.71e-06	4.85e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—AKT1—colon cancer	6.6e-06	4.77e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—AKT1—colon cancer	6.59e-06	4.76e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—EP300—colon cancer	6.56e-06	4.74e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—AKT1—colon cancer	6.55e-06	4.73e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TP53—colon cancer	6.49e-06	4.69e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PIK3CA—colon cancer	6.49e-06	4.69e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PIK3CA—colon cancer	6.49e-06	4.69e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—AKT1—colon cancer	6.34e-06	4.58e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—AKT1—colon cancer	6.34e-06	4.58e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TP53—colon cancer	6.28e-06	4.53e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TP53—colon cancer	6.28e-06	4.53e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PIK3CA—colon cancer	6.23e-06	4.5e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—HRAS—colon cancer	6.21e-06	4.48e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PTGS2—colon cancer	6.09e-06	4.4e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—AKT1—colon cancer	6e-06	4.34e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—HRAS—colon cancer	6e-06	4.34e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—HRAS—colon cancer	6e-06	4.34e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PIK3CA—colon cancer	5.73e-06	4.14e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—AKT1—colon cancer	5.7e-06	4.12e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PIK3CA—colon cancer	5.68e-06	4.1e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—AKT1—colon cancer	5.48e-06	3.96e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—AKT1—colon cancer	5.3e-06	3.83e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—AKT1—colon cancer	5.3e-06	3.83e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—AKT1—colon cancer	5.09e-06	3.68e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—EP300—colon cancer	5.06e-06	3.66e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CA—colon cancer	4.85e-06	3.51e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—AKT1—colon cancer	4.68e-06	3.38e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—AKT1—colon cancer	4.64e-06	3.35e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—AKT1—colon cancer	3.96e-06	2.86e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CA—colon cancer	3.75e-06	2.71e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—AKT1—colon cancer	3.06e-06	2.21e-05	CbGpPWpGaD
